LINCOLN PHARMACEUTICALS
|
|
BOM : 531633     NSE : LINCOLN     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 20,2022 |
Price(EOD): ₹ 283.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 567.60 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
LINCOLN PHARMACEUTICALS | -4.8% | -18.4% | -9.8% |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% | -0.8% | 28% |
DIVIS LABORATORIES | 2.1% | -3.3% | 4.4% |
DR REDDYS LABORATORIES | 9.2% | -1.1% | -24.4% |
CIPLA | 4.9% | -3.3% | 6.1% |
GLAND PHARMA | -1.3% | -6.3% | 1% |
PIRAMAL ENTERPRISES | 2.3% | -13.7% | 12% |
CADILA HEALTHCARE | 3.5% | -0.9% | -44% |
TORRENT PHARMACEUTICALS | 3.1% | -6.9% | -4.9% |
FUNDAMENTAL ANALYSIS OF LINCOLN PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF LINCOLN PHARMACEUTICALS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
9.12
P/E Calculated based on EPS of 31.11
[ Mar2021 - Consolidated Results ] 1.51
P/B Calculated based on Book Value of 187.65
[ Mar2021 - Consolidated Results ] 1.2
P/S Calculated based on Revenues of 472.124 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
16% -5% -1% |
SHARE PRICE MOMENTUM OF LINCOLN PHARMACEUTICALS
LINCOLN PHARMACEUTICALS vs SENSEX
DEBT OF LINCOLN PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0.02 0.13 0.05 |
0 0.02 0.12 0.05 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF LINCOLN PHARMACEUTICALS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF LINCOLN PHARMACEUTICALS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-14.43% -25.6% -28.93% -37.36% |
28.91% 14.45% 9.54% -12.37% |
QtrlyTrend |
-2 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
LINCOLN PHARMACEUTICALS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 4.1% | -8.7% | 16.8% |
S&P BSE MIDSMALLCAP | 3.7% | -8.4% | 12.6% |
S&P BSE ALLCAP | 3.2% | -5.8% | 10.3% |
S&P BSE HEALTHCARE | 2.8% | -6.4% | -4.8% |
You may also like the below Video Courses
FAQ about LINCOLN PHARMACEUTICALS
Is LINCOLN PHARMACEUTICALS good for long term investment?
As on May 20,2022, the Fundamentals of LINCOLN PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of LINCOLN PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is LINCOLN PHARMACEUTICALS UnderValued or OverValued?
As on May 20,2022, LINCOLN PHARMACEUTICALS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of LINCOLN PHARMACEUTICALS ?
As on May 20,2022, the Intrinsic Value of LINCOLN PHARMACEUTICALS is Rs. 285.71 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 243.66
Fair Value [Median EV / Sales Model] : Rs. 298.35
Fair Value [Median Price / Sales Model] : Rs. 285.71
Median Fair Value of LINCOLN PHARMACEUTICALS : Rs. 285.71
Is LINCOLN PHARMACEUTICALS trading at a Premium or Discount?
As on May 20,2022, LINCOLN PHARMACEUTICALS is trading at a Discount of -1% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
